Valeant Pharmaceuticals International Inc raised its offer for cosmetics products maker Obagi Medical Products Inc to $24 per share, a day after its initial bid was topped by German drugmaker Merz Pharma Group. Obagi and Valeant agreed to a deal last month in which Valeant offered $19.75 per share. However, Merz Pharma topped that with an offer of $22 per share.
Obagi Medical Products, Inc. (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Shares of OMPI remained unchanged at $22.88. In the past year, the shares have traded as low as $10.70 and as high as $22.96. On average, 476985 shares of OMPI exchange hands on a given day and today's volume is recorded at 136165.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX remained unchanged at $75.37. In the past year, the shares have traded as low as $42.47 and as high as $76.56. On average, 1331660 shares of VRX exchange hands on a given day and today's volume is recorded at 0.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 1.09% or $-0.84/share to $76.48. In the past year, the shares have traded as low as $43.99 and as high as $77.66. On average, 425803 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 0.
Source